Annovis Bio   Report issue

For profit Phase 2
Founded: Berwyn PA United States (2008)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2010
NCT01072812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

phenserine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Cognitive Dysfunction (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1